Analysis the frequency of using Aflibercept (8 mg) in the treatment of neovascular age-related macular degeneration and diabetic macular edema compared with other anti-VEGF agents
The use of aflibercept 8 mg in the treatment of nAMD and DME demonstrates a reduction in the number of intravitreal injections, accompanied by a significant reduction in the socioeconomic burden.
Authors
- Yu.V. Strunina
- A.Zh. Fursova
Institutions
- Novosibirsk State Medical University (RU)
- Krasnoyarsk Regional Clinical Hospital (RU)
- Dermatology Specialists (US)
Publication Details
- Journal
- Russian Annals of Ophthalmology
- Published
- 2025-12-23
- DOI
- https://doi.org/10.17116/oftalma202514106192
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00